- FDA Approves Lurbinectedin Combo for ES-SCLC Maintenance Medscape
- Estela Rodriguez: Lurbinectedin Plus Atezolizumab as Maintenance Therapy for ES- SCLC Oncodaily
- Jazz Pharmaceuticals stock maintains Buy rating at Stifel on FDA approval Investing.com
- FDA Approves Zepzelca Plus Tecentriq for Extensive-Stage Small Cell Lung Cancer Cure Today
- FDA OKs Zepzelca-Tecentriq combo; CSL Vifor’s layoffs Endpoints News